Medication safety in care homes is a fundamental part of protecting residents and delivering high-quality, person-centred care. Many people living in residential and nursing homes take several medicines, sometimes for complex or long-term health conditions. This makes safe prescribing, administration, recording and review essential.
In April 2026, the Care Quality Commission (CQC) updated its learning resources on medicines management, warning that poor medicines management can result in serious or even fatal harm. CQC expects providers to have effective systems for prescribing, handling, administering and monitoring medicines safely.
For care-home leaders, medication safety therefore needs to be treated as an organisation-wide responsibility rather than simply a task completed during medication rounds.
What Does Medication Safety Mean in a Care Home?
Medication safety means ensuring residents receive the right support with their medicines while minimising avoidable harm.
This starts with understanding each person’s individual needs. Some residents may manage their own medicines independently, while others may require staff support with ordering, storage, administration or monitoring.
NICE guidance states that care homes should maintain an up-to-date medicines policy covering areas such as medicines reconciliation, administration, storage, disposal, medication reviews, error reporting, staff competence, self-administration and covert medicines.
A strong medicines system should also respect residents’ preferences, capacity and right to participate in decisions about their treatment wherever possible.
Accurate Medication Records Are Essential
Poor record keeping can create significant risks.
Care homes need accurate and current information about what medicines a resident takes, why they are prescribed, when they should be administered and whether any special instructions apply.
NICE recommends maintaining accurate information in both residents’ care plans and medicines administration records. Information should also remain accurate when residents transfer between healthcare settings.
CQC guidance similarly emphasises the importance of medicines care plans. These should provide enough information for staff to understand how a person needs to be supported, including arrangements for when-required medicines, time-specific medicines and covert administration where relevant.
Digital social care records may make information easier to access and audit, but technology does not replace good governance. Records still need to be accurate, timely and reviewed by competent staff.
Staff Training and Competency Matter
Medicine administration should only be carried out by staff who have received appropriate training and have been assessed as competent for their responsibilities.
Training should not be viewed as a one-time exercise.
Managers should have systems for supervision, competency assessment and refresher learning, particularly where staff administer complex or high-risk medicines.
Staff should also know what to do when something is unclear. If a medicine instruction, dose or record appears inconsistent, employees should feel confident stopping and seeking advice from an appropriate healthcare professional rather than making assumptions.
A strong safety culture makes it easier for employees to raise concerns before mistakes occur.
Managing PRN and Time-Sensitive Medicines Safely
Some medicines need additional attention.
PRN, or “when required”, medicines are prescribed for situations where a resident may not need treatment at fixed times. CQC says records should explain why the medicine was given, the amount administered and, where relevant, whether it achieved the intended effect.
Care plans should also make clear when PRN medicines should be offered and how staff should recognise when a resident may need them.
Time-sensitive medicines create a different challenge. Medicines such as insulin and some treatments for Parkinson’s disease may need to be administered within specific timeframes. Delayed or omitted doses can potentially cause harm, making staff organisation and accurate records particularly important.
Medication Reviews Support Safer Care
Residents’ medicines should not remain unchanged simply because they have been prescribed for a long time.
NICE recommends multidisciplinary medication reviews that involve the resident and, where appropriate, their family or carers. Relevant professionals may include GPs, pharmacists, nurses and members of the care-home team.
The timing of reviews should reflect each resident’s individual health and care needs, but NICE states that the interval between planned medication reviews should be no longer than one year.
A medication review can consider whether medicines remain necessary, whether they are working effectively, whether the person is experiencing side effects and whether monitoring is required.
For older residents taking several medicines, regular reviews can be particularly important when health conditions, mobility, cognition or swallowing ability change.
Learn From Medication Errors
Even well-managed services can experience mistakes. What matters is how the organisation responds.
NICE recommends robust processes for identifying, reporting, reviewing and learning from medication-related problems.
Care-home leaders should therefore avoid creating a culture where employees are afraid to report errors.
A medication incident should prompt questions such as:
Was the care plan clear?
Was the medicine available when needed?
Did staffing contribute to the error?
Was training adequate?
Was communication between the care home, pharmacy and prescriber effective?
Looking for the underlying cause helps providers prevent similar incidents rather than simply responding to the individual mistake.
Person-Centred Medicines Management
Safe medicines management is not only about compliance.
Residents should be involved in decisions about their medicines wherever possible. This includes explaining what medicines are for, listening to concerns about side effects and supporting people who are able to manage some or all of their medicines independently.
Where a resident lacks capacity for a particular decision, providers must ensure that decisions are made through appropriate legal and professional processes.
The aim should always be to combine safety with dignity, choice and independence.
Sheth Jeebun’s Leadership Approach to Safe Care
Medication safety also demonstrates why experienced care-home leadership matters.
Published information about Sheth Jeebun describes a career that began in registered nursing before progressing into ward management, nursing-home development and senior healthcare leadership. His experience has included clinical care, staff coordination, quality assurance, regulatory compliance and operational oversight.
This combination of clinical understanding and management experience is particularly relevant to medicines governance.
Frontline staff administer and monitor medicines, but leaders create the systems around them. Managers determine whether staff receive appropriate training, whether audits identify recurring problems, whether incidents lead to learning and whether communication with pharmacists, GPs and other healthcare professionals is effective.
Sheth Jeebun’s documented focus on staff development, safety and maintaining care standards reflects the wider principle that medication safety depends on leadership as much as it depends on individual procedures.
How Care-Home Leaders Can Strengthen Medication Safety
Rather than treating medicines audits as a paperwork exercise, leaders should use them to identify patterns and improvement opportunities.
Regularly review medicines policies, MAR records, missed or delayed doses, PRN administration, medication incidents and staff competency assessments.
Managers should also ensure that lessons from medication errors reach the wider team.
Where recurring problems appear, actions should be documented, assigned and reviewed to determine whether they have actually improved practice.
This turns medicines management from a reactive process into part of continuous quality improvement.
Conclusion
Medication safety in care homes in 2026 depends on accurate records, competent staff, effective medication reviews, person-centred care and strong leadership.
Current CQC guidance makes clear that poor medicines management can cause serious harm, while NICE guidance provides a practical framework for safe administration, monitoring, review and governance.
For care-home leaders, the goal should not simply be to demonstrate that a medicines policy exists. The real measure of good governance is whether that policy works consistently in everyday practice.
By combining clear procedures with staff development, open reporting, professional collaboration and experienced leadership, care homes can reduce medication risks while helping residents receive treatment safely, respectfully and according to their individual needs.
